Resultados de la búsqueda 271-280 of 18757 for Two-phase

  1. Oncología (médica) - Ensayos clínicos

    In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of the study. Mayo Clinic will not be participating in the QTC sub-study ...

  3. Oncología (médica) - Ensayos clínicos

    In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase III trial compares memantine hydrochloride and whole ... Phase 2 part to further assess the effectiveness and safety of JCAR017 ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...

  6. Oncología (médica) - Ensayos clínicos

    In the phase II part, to evaluate the preliminary antitumor activity of two ... This is a Phase 2 global, multi-center, open-label study to assess the ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... phase 2 dose (RP2D) of APG-2575. A Study to Evaluate Immunotherapy and Ovarian Function Among Pre-menopausal Melanoma Survivors. Rochester, Minn. The ...

  8. Oncología (médica) - Ensayos clínicos

    This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... phase 2 dose (RP2D) of APG-2575. A Study to Evaluate Immunotherapy and Ovarian Function Among Pre-menopausal Melanoma Survivors. Rochester, Minn. The ...

  10. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...